COMP-angiopoietin1 Gene Transfer Enhances Cutaneous Wound Healing by Promoting Angiogenesis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Angiogenesis is crucial for wound healing and exogenous supplements of the angiogenic growth factors have been known to promote cutaneous wound healing. Angiopoietin (Ang) 1 is a recently discovered angiogenic factor and there have been few studies of its effect on cutaneous wound healing. Objective: We examined the effect of Ang 1 on cutaneous wound healing. Methods: Cartilage oligomeric matrix protein (COMP)-Ang 1 (Ade-COMP-Ang 1)- was intravenously injected to rats two days before surgery creating full-thickness wounds. The clinical wound healing rate and the number of vessels in the skin samples were evaluated on days 3, 7 and 14 post operation. Results: At post-operation day 3, 7 and 14, the clinical wound healing rate was 38.3%, 59.4% and 92.1%, respectively, in the Ade-COMP-Ang 1-treated group, compared with 20.5%, 47.5% and 87.3%, respectively, in the Ade-LacZ-treated group. There were significant differences in the results of day 3 and day 7 between two groups (p＜0.05). Histopathologically, the number of the vessels of the Ade-COMP-Ang 1-treated group was 73.7, 94.1 and 62.7 at day 3, 7 and 14, compared with that of the Ade-LacZ-treated group, 53.5, 83.9, and 56.9. The differences in the results of the two groups were statistically significant (p＜0.05). Conclusion: These results indicate that Ade-COMP-Ang 1 therapy significantly accelerats wound healing by promoting angiogenesis. However, further study using Ade-COMP-Ang 1 gene therapy for chronic wounds in which the formation of new blood vessels is impaired is needed in the near future.
Abstract
Background: Angiogenesis is crucial for wound healing and exogenous supplements of the angiogenic growth factors have been known to promote cutaneous wound healing. Angiopoietin (Ang) 1 is a recently discovered angiogenic factor and there have been few studies of its effect on cutaneous wound healing. Objective: We examined the effect of Ang 1 on cutaneous wound healing. Methods: Cartilage oligomeric matrix protein (COMP)-Ang 1 (Ade-COMP-Ang 1)- was intravenously injected to rats two days before surgery creating full-thickness wounds. The clinical wound healing rate and the number of vessels in the skin samples were evaluated on days 3, 7 and 14 post operation. Results: At post-operation day 3, 7 and 14, the clinical wound healing rate was 38.3%, 59.4% and 92.1%, respectively, in the Ade-COMP-Ang 1-treated group, compared with 20.5%, 47.5% and 87.3%, respectively, in the Ade-LacZ-treated group. There were significant differences in the results of day 3 and day 7 between two groups (p＜0.05). Histopathologically, the number of the vessels of the Ade-COMP-Ang 1-treated group was 73.7, 94.1 and 62.7 at day 3, 7 and 14, compared with that of the Ade-LacZ-treated group, 53.5, 83.9, and 56.9. The differences in the results of the two groups were statistically significant (p＜0.05). Conclusion: These results indicate that Ade-COMP-Ang 1 therapy significantly accelerats wound healing by promoting angiogenesis. However, further study using Ade-COMP-Ang 1 gene therapy for chronic wounds in which the formation of new blood vessels is impaired is needed in the near future.
참고문헌 (23)
- Yancopoulos GD, "Vascular-specific growth factors and blood vessel formation", Nature, 407, pp.242~248
- K mpfer H, "Expressional regulation of angiopoietin-1 and 2 and the Tie-1 and 2 receptor tyrosine kinases during cutaneous wound healing: A comparative study of normal and impaired repair", Lab Invest, 81, pp.361~373 (2001)
- Colwell AS, "Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair", Plast Reconstr Surg, 115, pp.204~212 (2005)
- Yao F, "Age and growth factors in porcine full-thickness wound healing", Wound Repair Regen, 9, pp.371~377 (2001)
- Drinkwater SL, "Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers", J Vasc Surg, 38, pp.1106~1112 (2003)
- Romano Di Peppe S, "Adenovirus-mediated VEGF165 gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice", Gene Therapy, 9, pp.1271~1277 (2002)
- Galeano M, "Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse", Diabetes, 53, pp.2509~2517 (2004)
- Cianfarani F, "Granulocyte", macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed, 2006, pp.154, 34~41
- Davis S, "Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning", Cell, 87, pp.1161~1169 (1996)
- Cho CH, "COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity", PNAS, 101, pp.5547~5552 (2004)
- Cho CH, "Designed angiopoietin-1 variant, COMP-Ang1, protects against radiationinduced endothelial cell apoptosis", PNAS, 101, pp.5553~5558 (2004)
- Suri C, "Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis", Cell, 87, pp.1171~1180 (1996)
- Sato TN, "Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system", Proc Natl Acad Sci USA, 90, pp.9355~9358 (1993)
- Suri C, "Increased vascularization in mice overexpressing angiopoietin-1", Science, 282, pp.468~471 (1998)
- Jones MK, "Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1", Gastroenterology, 121, pp.1040~1047 (2001)
- Jung H, "Adenovirus-mediated angiopoietin-1 gene therapy enhances skin flap survival", Microsurgery, 23, pp.374~380 (2003)
- 김경문, "배양된 기니픽 진피 섬유모세포의 자가이식을 이용한 창상 치유에 관한 연구", 대한피부과학회지, 43(5), pp.576~586 (2005), 대한피부과학회
- Lee RJ, "VEGF gene delivery to myocardium: deleterious effects of unregulated expression", Circulation, 103, pp.898~901 (2000)
- Thurston G, "Angiopoietin-1 protects the adult vasculature against plasma leakage", Nat Med, 6, pp.460~463 (2000)
- Thurston G, "Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1", Science, 286, pp.2511~2514 (1999)
- Baffert F, "Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules", Am J Physiol Heart Circ Physiol, 290, pp.H107~H118 (2006)
- Jho D, "Angiopoietin-1 opposes VEGF-induced increase in endothelial permeability by inhibiting TRPC1-dependent Ca2＋ influx", Circ Res, 96, pp.1282~1290 (2005)
- Galeano M, "Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse", Diabetologia, 46, pp.546~555 (2003)